SOPHIA GENETICS SA (SOPH) Stock Price, Quote, News and Overview

What is the stock price of SOPHIA GENETICS SA today?

The current stock price of SOPH is 3.16 USD. The price increased by 4.29% in the last trading session.

What is the ticker symbol for SOPHIA GENETICS SA stock?

The exchange symbol of SOPHIA GENETICS SA is SOPH and it is listed on the Nasdaq exchange.

On which exchange is SOPH stock listed?

SOPH stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for SOPHIA GENETICS SA stock?

12 analysts have analysed SOPH and the average price target is 6.94 USD. This implies a price increase of 119.49% is expected in the next year compared to the current price of 3.16. Check the SOPHIA GENETICS SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is SOPHIA GENETICS SA worth?

SOPHIA GENETICS SA (SOPH) has a market capitalization of 211.18M USD. This makes SOPH a Micro Cap stock.

How many employees does SOPHIA GENETICS SA have?

SOPHIA GENETICS SA (SOPH) currently has 430 employees.

What are the support and resistance levels for SOPHIA GENETICS SA (SOPH) stock?

SOPHIA GENETICS SA (SOPH) has a support level at 2.93 and a resistance level at 3.12. Check the full technical report for a detailed analysis of SOPH support and resistance levels.

Is SOPHIA GENETICS SA (SOPH) expected to grow?

The Revenue of SOPHIA GENETICS SA (SOPH) is expected to grow by 12.64% in the next year. Check the estimates tab for more information on the SOPH EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy SOPHIA GENETICS SA (SOPH) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of SOPH, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of SOPH, evaluating the profitability, health, valuation and growth aspects
• SOPHIA GENETICS SA (SOPH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• SOPHIA GENETICS SA (SOPH) Sales and EPS estimates to see what analysts future expectations are.
• SOPHIA GENETICS SA (SOPH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• SOPHIA GENETICS SA (SOPH) Insider and Institutional Ownership to learn about the owners and their transactions.
• SOPHIA GENETICS SA (SOPH) Stock Chart to make your own analysis
• SOPHIA GENETICS SA (SOPH) Latest news and press-releases to stay up to date.

Does SOPHIA GENETICS SA (SOPH) stock pay dividends?

SOPH does not pay a dividend.

When does SOPHIA GENETICS SA (SOPH) report earnings?

SOPHIA GENETICS SA (SOPH) will report earnings on 2025-05-06, before the market open.

What is the Price/Earnings (PE) ratio of SOPHIA GENETICS SA (SOPH)?

SOPHIA GENETICS SA (SOPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.95).

What is the Short Interest ratio of SOPHIA GENETICS SA (SOPH) stock?

The outstanding short interest for SOPHIA GENETICS SA (SOPH) is 0.08% of its float. Check the ownership tab for more information on the SOPH short interest.

ChartMill assigns a fundamental rating of 3 / 10 to SOPH. The financial health of SOPH is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months SOPH reported a non-GAAP Earnings per Share(EPS) of -0.95. The EPS increased by 22.13% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to SOPH. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 6.86% and a revenue growth 12.64% for SOPH